twentyfour Skincare Named INNOCOS Beauty & Longevity CHOICE Awards Finalist for Cellular Signalling & Longevity Mechanisms

Key Highlights:
Introduction
Why the INNOCOS Beauty & Longevity CHOICE Awards Matter
Cellular Signalling and Longevity Mechanisms: The Science That Matters for Skin
How Topical Systems Can Mirror Regenerative Medicine Pathways
What twentyfour Skincare Is Being Recognized For
Evidence Standards: What Counts as Scientific Integrity in Beauty and Longevity
The Consumer and Clinical Impact of a Scientific Nomination
Ingredients, Mechanisms and the Line Between Claim and Proof
Market Context: Why Beauty Longevity Is a Fast-Growing Category
Real-World Examples and Comparable Approaches
Limitations, Risks and Points of Caution
Evaluating Longevity-Focused Skincare: A Practical Checklist for Consumers and Clinicians
Greenville to Global: What Local Brands Gain from International Recognition
The Role of Clean and Natural Ingredients in Mechanism-Based Formulation
What Comes Next: Trials, Transparency and the Path to Broader Adoption
What Consumers Should Expect from Twentyfour’s Regimen
Broader Implications for the Beauty Industry
Final Thoughts on the Nomination’s Significance
FAQ

Key Highlights:

Greenville-based twentyfour skincare has been selected as a finalist in the 2025–2026 INNOCOS Beauty & Longevity CHOICE Awards in the Cellular Signalling & Longevity Mechanisms category, recognizing its science-driven approach to skin health.
The brand’s flagship launches—StepZero™ Age Reversing Powder and HYDRíQ™ Age Reversing Hydrator—launched in August 2025 and have been positioned as gentle, evidence-minded products that support cell turnover, collagen restoration, and barrier repair.
The INNOCOS awards prioritize biological mechanisms, scientific integrity, and potential impact on long-term human health, signaling a shift in consumer and professional expectations toward verifiable, mechanism-based skincare.

Introduction

Recognition from a jury of longevity scientists, dermatologists, medical doctors and industry experts reframes a skincare brand’s proposition. For twentyfour skincare, a Greenville-based company that launched two flagship products in August 2025, the nomination as an INNOCOS Beauty & Longevity CHOICE Awards finalist validates a development path centered on measurable biological mechanisms rather than marketing alone. The award’s Cellular Signalling & Longevity Mechanisms category focuses attention on interventions that influence the cellular processes underlying skin aging—cell turnover, collagen production and barrier integrity—areas where topical systems can deliver tangible benefits when backed by robust science.

Jenny Pancoast, founder and president of XXIV (twentyfour skincare), framed the recognition as confirmation of the brand’s commitment to clean, natural and scientifically effective actives. That language captures a broader shift: consumers and clinicians now demand clarity about how products work, evidence for claims and safety that aligns with longer-term health priorities. This article examines what the INNOCOS nomination means for twentyfour, the science behind cellular signalling and skin longevity, how topical interventions can emulate regenerative medicine pathways, and what consumers and professionals should look for as the beauty and longevity fields converge.

Why the INNOCOS Beauty & Longevity CHOICE Awards Matter

The INNOCOS awards emerged to provide a rigorous standard in a market crowded with aspirational claims and inconsistent evidence. Judges evaluate submissions on their underpinning biological mechanisms, the scientific rigor supporting those mechanisms, and the product’s realistic potential to influence long-term human health and aging. That evaluation brings technical scrutiny to what often has been presented as lifestyle marketing.

For a brand to be named a finalist, it must present a credible narrative connecting ingredient function, formulation design and measurable outcomes. The jury typically includes longevity researchers who understand pathways such as cellular senescence, ECM (extracellular matrix) remodeling and barrier biology; dermatologists who assess topical efficacy and safety; and industry professionals who weigh commercial viability and regulatory compliance. The award thus functions as both a stamp of scientific credibility and a consumer-facing guidepost.

Twentfour’s selection recognizes not only product formulation but also messaging aligned with evidence-based mechanisms. That alignment reduces the gap between laboratory understanding of skin aging and consumer-facing product claims. The award’s influence extends beyond publicity; it helps clinicians and retailers filter innovations that merit clinical adoption or clinical trials, and it encourages firms to invest in transparent science rather than ambiguous buzz.

Cellular Signalling and Longevity Mechanisms: The Science That Matters for Skin

Skin aging results from interacting biological processes: declining cellular renewal, fragmentation and loss of collagen and elastin in the dermis, chronic low-level inflammation, and deterioration of the barrier function that preserves hydration and prevents microbial incursions. Cellular signalling pathways coordinate many of these changes. Understanding them clarifies how topical and systemic interventions can produce durable improvements.

Key pathways and processes reviewed by longevity scientists and dermatologists include:

Cell turnover and epidermal renewal: Keratinocyte proliferation and differentiation maintain epidermal structure. Agents that modulate this process accelerate removal of damaged or dysregulated cells and expose healthier layers, improving texture and tone.
Collagen synthesis and ECM remodeling: Fibroblasts produce collagen, elastin and other matrix proteins. Signals that stimulate fibroblast activity or protect matrix components promote firmness and structural integrity.
Barrier repair and lipid balance: The stratum corneum relies on ceramides, fatty acids and cholesterol to prevent transepidermal water loss. When the barrier is compromised, inflammation and accelerated aging follow.
Cellular senescence and inflammaging: Senescent cells adopt a secretory phenotype that promotes inflammation and extracellular matrix breakdown. Reducing senescent cell burden or mitigating their signaling reduces pro-aging cascades.
Oxidative stress and DNA damage response: Reactive oxygen species and cumulative photodamage degrade proteins and nucleic acids. Antioxidant defenses and DNA repair pathways influence longevity at the tissue level.

Topical formulations cannot alter systemic longevity drivers like telomere attrition across the body. They can, however, modulate these localized pathways in the skin through targeted actives and delivery systems. The INNOCOS category that recognized twentyfour specifically evaluates how formulations engage such pathways with plausible, evidence-backed mechanisms.

How Topical Systems Can Mirror Regenerative Medicine Pathways

Regenerative medicine focuses on restoring structure and function, typically through stem cells, growth factors, or molecular modulators that re-establish tissue homeostasis. Topical skincare cannot replace surgical or cell-based interventions, but modern formulations increasingly borrow regenerative principles:

Signaling to resident cells: Peptides and small molecules mimic growth-factor signals that tell fibroblasts to increase matrix production. They operate as informational cues rather than structural replacements.
Removing dysfunctional elements: Exfoliants and enzymatic treatments accelerate removal of damaged superficial cells, enabling regeneration from healthier progenitor populations beneath.
Protecting and rebuilding microenvironment: Lipid-replenishing and hydrating agents restore conditions for optimal cell function. A repaired barrier reduces inflammatory signaling that impedes regeneration.
Modulating inflammation and senescence-associated signals: Antioxidants, anti-inflammatory botanicals, and compounds that influence senescence-associated secretory phenotype reduce the chronic pro-degradative signaling that accelerates matrix breakdown.

When a topical system integrates these approaches with appropriate concentrations, compatible vehicles for delivery and safety profiling, it can approximate the aims of regenerative therapies at the level of tissue health and visible aging outcomes. This is the framework against which INNOCOS judges evaluate products in the Cellular Signalling & Longevity Mechanisms category.

What twentyfour Skincare Is Being Recognized For

The INNOCOS nomination highlights twentyfour’s focus on cellular mechanisms tied to skin vitality. The brand’s stated priorities—supporting cell turnover, restoring collagen, and improving barrier repair—match the domains longevity scientists consider most relevant to cutaneous aging.

Two flagship products anchor the brand’s launch narrative:

StepZero™ Age Reversing Powder: Presented as a component of a topical system designed to prepare and support the skin’s regenerative processes. Powder formulations often aim to deliver active molecules in a stable, targeted manner or to produce controlled exfoliation when mixed into topical vehicles. As a “StepZero,” the product’s positioning suggests a preparatory role—priming the skin to respond to subsequent interventions.
HYDRíQ™ Age Reversing Hydrator: Marketed as an age-reversing hydrator intended to restore barrier function and hydration while supporting mechanisms that underpin long-term skin health. Hydrators focused on barrier repair typically include humectants, emollients and compounds that promote lipid synthesis to reduce transepidermal water loss and inflammatory signaling.

The company describes the line as “clean, natural, and highly effective active ingredients.” That messaging reflects consumer preferences and regulatory realities: transparency around ingredient origin and absence of controversial additives matters for purchase and clinical adoption decisions. The INNOCOS jury’s selection implies twentyfour presented credible mechanistic rationale and likely some level of empirical backing, even if peer-reviewed clinical trials have yet to be widely publicized.

Jenny Pancoast framed the award recognition as confirmation of twentyfour’s mission to restore skin health “from the inside-out,” language that connects topical action to systemic notions of vitality while remaining focused on measurable skin outcomes. The brand’s early market traction suggests professionals and consumers find that positioning credible.

Evidence Standards: What Counts as Scientific Integrity in Beauty and Longevity

Scientific integrity in beauty demands clarity across multiple dimensions: transparent ingredient lists, disclosure of active concentrations, quality of evidence (in vitro, ex vivo, clinical), independent replication where possible, and safety data for intended use. The INNOCOS evaluation emphasizes biological plausibility and measurable outcomes rather than solely marketing claims.

Degrees of evidence commonly encountered:

Mechanistic in vitro data: Tests on cell cultures demonstrating that an ingredient modulates a pathway—e.g., increasing collagen gene expression in fibroblasts—provide a plausible mechanism but do not guarantee efficacy in complex skin.
Ex vivo or organotypic skin models: These bridge the gap between cells and actual skin tissue, offering insights into penetration and tissue-level response.
Small-scale clinical trials: Well-designed studies on human volunteers that use objective endpoints—histology, transepidermal water loss (TEWL), imaging of collagen density—deliver stronger evidence.
Large, randomized controlled trials (RCTs) and real-world effectiveness data: These are the gold standard but remain rare in cosmetic science due to cost and regulatory framing of cosmetics versus drugs.

Brands that secure awards like INNOCOS typically present a mix of mechanistic rationale and human data. The award is not a substitute for peer-reviewed RCTs, but it flags products that meet a higher bar than marketing alone.

The Consumer and Clinical Impact of a Scientific Nomination

For consumers, an INNOCOS finalist badge simplifies decision-making. It signals a product comes with a documented mechanistic approach and scrutiny from experts. For clinicians—dermatologists, cosmetic physicians, medspa directors—such recognition reduces the risk of recommending products that are unsupported or misbranded. The nomination can accelerate adoption in professional contexts where safety, predictability and reproducible outcomes are essential.

Retailers and spas also use such distinction to curate offerings. Product assortments that prioritize evidence-based formulations align with professional standards and can justify higher price points when efficacy backs the claims. A Greenville brand earning global recognition demonstrates how local entrepreneurs can compete in a market increasingly oriented to scientific credibility.

Ingredients, Mechanisms and the Line Between Claim and Proof

Many active ingredients have well-characterized effects on the pathways INNOCOS judges prioritize. Retinoids increase epidermal turnover and stimulate collagen synthesis; peptides can signal fibroblasts to produce matrix proteins; niacinamide supports barrier lipids and reduces transepidermal water loss; antioxidants neutralize reactive oxygen species that otherwise degrade proteins and nucleic acids.

Three considerations distinguish meaningful product design from cosmetic marketing:

Concentration and formulation: An ingredient’s effect depends on its concentration and whether the vehicle supports penetration to relevant layers. Low levels of an active may be sufficient for maintenance but not for therapeutic change.
Stability and delivery: Some actives degrade in air or light; powders and encapsulation technologies protect them. Delivery systems that release actives where they are needed increase the likelihood of effect.
Safety and tolerability: Aggressive actives produce results but can compromise the barrier if used incorrectly. Combining barrier-supportive ingredients with actives that increase turnover improves tolerability and reduces inflammation-driven aging.

Twentyfour’s stated focus on gentle, science-backed formulations aligns with these principles. The brand’s StepZero and HYDRíQ components suggest a regimen model: prepare and remove dysfunctional elements, then replenish and signal repair while maintaining barrier integrity.

Market Context: Why Beauty Longevity Is a Fast-Growing Category

Consumer preferences have shifted from simple anti-wrinkle promises to demands for verifiable outcomes and long-term health compatibility. That shift reflects greater public access to scientific information and the emergence of longevity science as a lifestyle discipline. Product developers and investors have noticed, driving funding, research and the emergence of awards such as INNOCOS that separate credible innovations from hype.

Three market dynamics are notable:

Professionalization of claims: Dermatologists and longevity scientists increasingly consult on product development, elevating the bar for mechanistic grounding.
Convergence with wellness: Skincare is no longer only topical. Consumers view it as part of an integrated approach to health spanning sleep, nutrition, exercise and targeted supplements.
Regulatory tightening and consumer skepticism: Authorities remain attentive to product claims that overstep the bounds of cosmetics into drug claims. Consumers, in turn, are wary of brands that promise systemic transformation without evidence.

Twentyfour’s strategy appears to target professionals and informed consumers who value evidence and tolerability. The initial market trust reported for the brand’s two launches indicates resonance with that audience.

Real-World Examples and Comparable Approaches

Clinical practice offers practical illustrations of how mechanism-focused skincare operates:

A dermatology clinic integrating a retinoid-based resurfacing regimen with barrier repair creams typically observes improvement in texture, pigmentation and collagen-related firmness. The regimen’s success relies on balancing exfoliation with hydration.
Medspas offering peptide-rich serums post-procedure use those agents to support fibroblast-mediated remodeling, while concurrent use of ceramide-rich emollients prevents cytokine-driven inflammation that would otherwise hinder recovery.
Professional product lines that pair a preparatory exfoliant with a hydrating, active-containing serum often achieve better tolerance and adherence, because the preparatory step enhances penetration and the hydrator reduces irritation.

These examples reflect the same logic behind twentyfour’s two-step product narrative: prime, then repair. The critical difference between reputable regimens and less effective ones is the evidence base for each ingredient, concentration transparency and the quality of clinical endpoints used to validate outcomes.

Limitations, Risks and Points of Caution

Even evidence-backed topicals face constraints. Consumers and practitioners should recognize boundaries to avoid unrealistic expectations:

Scope of effect: Topical systems impact skin structure and function locally. They cannot reverse systemic aging or address internal disease processes.
Heterogeneity of response: Genetic background, prior UV exposure, skin type and microbiome composition influence outcomes. What works for one person may produce minimal change for another.
Overreliance on single-ingredient narratives: No single molecule fully controls complex aging networks. Multifaceted regimens that integrate protection (sunscreen), repair (barrier lipids), and signaling (peptides, retinoids) offer the best prospects.
Lag between mechanism and clinical proof: Mechanistic data is valuable but requires human studies with appropriate endpoints to fully substantiate claims.
Regulatory and labeling complexity: Cosmetic labels avoid drug claims. Brands must carefully frame benefits as cosmetic improvements unless they pursue clinical drug approval pathways.

Brands that navigate these limitations transparently—by disclosing what their products can and cannot do, publishing human data, and advising on realistic timelines—build durable trust.

Evaluating Longevity-Focused Skincare: A Practical Checklist for Consumers and Clinicians

When assessing a brand like twentyfour or any other contender in the beauty-longevity space, consider the following practical criteria:

Mechanistic rationale: Does the brand explain how its ingredients interact with known pathways—cell turnover, collagen synthesis, barrier repair?
Evidence level: Are there human studies? If so, are endpoints objective (histology, TEWL, imaging) and are the studies appropriately controlled?
Ingredient transparency: Are active concentrations disclosed? Do labels specify forms of actives (e.g., retinol vs. retinyl palmitate) and their stability?
Formulation design: Does the regimen pair actives with barrier-supporting elements to maintain tolerability?
Safety data: Is there safety testing for the intended use population, including sensitive skin groups?
Third-party review: Has the product or brand been evaluated by independent experts or awarded by panels that include scientists and clinicians?
Practical fit: Does the regimen align with a user’s lifestyle and skin goals? Is the product accessible and supported by professional guidance when needed?

Twentyfour’s INNOCOS finalist status addresses the “third-party review” criterion. For clinicians, the next questions concern the depth of the human data and how the products perform in real-world clinical populations.

Greenville to Global: What Local Brands Gain from International Recognition

A brand headquartered outside traditional beauty industry hubs benefits strategically from global recognition. Awards and finalist designations increase visibility among distributors, clinicians and consumers, accelerating market entry. For Greenville and similar communities, a local success story generates employment, attracts talent and promotes regional clusters for product development and small-scale manufacturing.

For twentyfour, the INNOCOS mention does more than validate product science; it amplifies a regional brand on an international stage. That amplification helps attract partnerships with research institutions, supply-chain partners and professional channels. Local manufacturing and clean-label sourcing can become competitive advantages when coupled with recognition for scientific rigor.

The Role of Clean and Natural Ingredients in Mechanism-Based Formulation

“Clean” and “natural” are not interchangeable with efficacy. A scientifically credible product must demonstrate that natural ingredients either contain active molecules at effective concentrations or that their extracts reproducibly modulate target pathways. Clean labeling plays an important role in consumer acceptance, regulatory clarity and allergy risk management, but it must be paired with mechanism-based formulation.

Key considerations when integrating natural actives:

Standardization: Botanical extracts vary between harvests. Standardization to active markers ensures consistency.
Purity and contaminants: Natural sources can carry heavy metals, pesticides or adulterants unless rigorously tested.
Synergy vs. antagonism: Complex extracts may contain multiple molecules that interact positively or negatively with other actives in a formulation.
Sustainability: Sourcing natural actives responsibly supports brand credibility and long-term supply security.

Twentyfour’s claim of “clean, natural, and highly effective active ingredients” signals an intention to balance consumer preferences with mechanistic efficacy. Demonstrating standardization and stability will be essential for clinicians and scientists evaluating the depth of their evidence.

What Comes Next: Trials, Transparency and the Path to Broader Adoption

Awards create visibility but do not replace rigorous clinical validation. The logical next steps for brands seeking broad professional adoption include:

Conducting randomized, controlled clinical trials with objective endpoints relevant to cellular signalling and longevity, such as collagen density measured by imaging or histological markers of proliferation and senescence.
Publishing results in peer-reviewed journals to allow independent scrutiny and replication.
Disclosing full formulations and concentrations where possible, so clinicians can assess plausibility and safety.
Collaborating with academic groups to explore mechanistic questions and develop biomarkers that track treatment response over time.
Building educational programs for clinicians and consumers that explain why and how a product works, appropriate sequencing in regimens and management of adverse events.

A finalist designation can catalyze investment in these steps. For twentyfour, establishing a pipeline of transparent clinical evidence will convert early market trust into long-term clinical acceptance and consumer loyalty.

What Consumers Should Expect from Twentyfour’s Regimen

Based on the brand’s public positioning and the INNOCOS recognition, consumers should expect a regimen whose architecture reflects current best practice for mechanism-based skincare:

Preparation: A product that primes the skin—removing superficial barriers to penetration and exfoliating damaged cells—without compromising barrier integrity.
Signal and support: Follow-up products that provide molecular cues to increase matrix production while simultaneously restoring lipids and hydration.
Tolerability: An emphasis on gentle, well-tolerated actives paired with repair-focused components to reduce irritation.
Gradual, measurable improvement: Outcomes focused on texture, hydration, and firmness measured over weeks to months rather than overnight transformations.

Professional guidance can optimize outcomes. Dermatologists can advise on integration with prescription retinoids, procedures and sun protection—critical complements to any longevity-focused topical regimen.

Broader Implications for the Beauty Industry

The INNOCOS nomination reflects a broader maturation of the beauty industry. Brands that invest in mechanistic understanding, replicate findings in human studies and communicate transparently will capture market share among discerning consumers and professionals. Awards that stress scientific integrity accelerate that market segmentation by valorizing data over marketing narratives.

The rise of longevity-focused beauty fosters cross-disciplinary collaboration: molecular biologists, dermatologists, formulation chemists and clinicians converging on shared objectives. That collaboration yields more sophisticated products but also raises the bar for evidence and ethical marketing. Consumers will benefit when product performance is demonstrable, when safety is prioritized, and when practitioners can rely on credible, peer-reviewed data to inform recommendations.

Final Thoughts on the Nomination’s Significance

Being named a finalist by a jury that includes longevity scientists and clinicians places twentyfour skincare in a selective group of companies pushing beyond cosmetic promises toward mechanism-based formulations. The brand’s combination of a two-step regimental approach, stated goals of supporting cell turnover, restoring collagen and repairing barrier function, and explicit attention to natural, clean actives aligns with the standards INNOCOS seeks to promote.

For consumers and clinicians alike, the nomination should prompt a closer look: evaluate the quality of the evidence behind the claims, consider how products fit into broader skin health strategies, and monitor future clinical disclosures. For twentyfour, the recognition offers a platform to deepen scientific validation and to expand the conversation around how topical products can responsibly and effectively contribute to skin longevity.

FAQ

Q: What does it mean that twentyfour skincare is an INNOCOS finalist? A: The INNOCOS Beauty & Longevity CHOICE Awards assess products on their biological mechanisms, scientific integrity and realistic potential to affect long-term human health and aging. Being a finalist indicates that twentyfour’s submissions—its product formulations and supporting data—were judged by a panel of longevity scientists, dermatologists, medical doctors and industry experts to be among the most scientifically grounded offerings in the Cellular Signalling & Longevity Mechanisms category.

Q: Do StepZero™ and HYDRíQ™ have published clinical data? A: The brand has positioned those products as science-backed and reports early marketplace trust. Finalist selection implies the brand presented mechanistic rationale and likely supporting evidence to the INNOCOS jury. For clinicians and consumers seeking detailed validation, request or review the brand’s human study data, study design, endpoints and any peer-reviewed publications or independent trial results.

Q: How can topical products influence cellular signalling and longevity mechanisms? A: Topical products can modulate skin-specific pathways by delivering molecules that influence keratinocyte proliferation, fibroblast activity, extracellular matrix synthesis, antioxidant defenses and barrier lipid production. The degree of effect depends on ingredient selection, concentration, vehicle stability and the ability of the compound to reach the relevant skin layers.

Q: Are “clean” and “natural” ingredients inherently better for longevity-focused skincare? A: Not inherently. Natural ingredients can contain efficacious molecules, but they require standardization, purity testing and stability control to perform reliably. A formulation’s efficacy rests on the active’s mechanism, concentration and delivery, whether the molecule is natural or synthetic. “Clean” labeling addresses consumer preferences for ingredient sourcing and absence of certain additives but must be paired with evidence of efficacy.

Q: What should professionals look for when recommending a longevity-focused skincare product? A: Prioritize formulations with transparent ingredient lists, clear mechanistic explanations, published human evidence with objective endpoints where available, compatible regimen design (e.g., pairing exfoliation with barrier support), and documented safety data. Third-party recognition by panels that include scientists and clinicians can be helpful but should not replace assessment of the available data.

Q: Can topical skincare reverse systemic aging? A: No. Topical skincare affects skin structure and function locally. It can improve skin cellular turnover, matrix production and barrier function, which influence visible aging of the skin and local tissue health. Systemic aging involves whole-body processes—telomere dynamics, metabolic regulation, immune aging—that topical applications cannot address.

Q: What are reasonable expectations for results and timelines? A: Improvements in hydration and skin surface texture can appear within days to weeks. Changes in collagen content and dermal remodeling typically require months to observe with objective measures. Realistic regimens combine daily photoprotection, adherence to the topical protocol and integration with supportive lifestyle measures for the best outcomes.

Q: How should consumers verify claims from brands in the beauty-longevity space? A: Look for human clinical studies with clear endpoints, transparent disclosure of active concentrations, third-party or expert panel recognition, and peer-reviewed publications where available. Consult dermatologists when considering potent actives or combining multiple interventions.

Q: Where can I learn more about twentyfour skincare’s evidence and availability? A: For the most current information on studies, ingredient disclosures and purchase options, consult the brand’s official communications channels and the product labeling. Clinicians can request technical dossiers or study data from the company directly to assess suitability for professional use.